Jeff was quoted today in the NY times at the Lotronex meeting with the FDA.In answer to Public Citizen, the Times said:"But some patients disagree. One, who will speak at the meeting today, is Jeffrey Roberts, who works in the brokerage industry and who has founded several self-help groups for patients. Mr. Roberts said, "We think the F.D.A. is learning that quality-of-life issues are very significant, rather than just curing an illness, and people are willing to accept some level of risk in order to have a better quality of life."The full article is at http://www.ibsgroup.org/other/NYTimesApr232002.html This was earlier in the day so there was later information. JeanG